Literature DB >> 31598397

Tumor-associated macrophages (TAMs) depend on Shp2 for their anti-tumor roles in colorectal cancer.

Saisai Wang1, Yuanyuan Yao1, Huixia Li1,2, Gang Zheng3, Sen Lu1, Wenbin Chen1.   

Abstract

Tumor associated macrophages (TAMs) in tumor microenvironment can interact with tumor cells and are related to tumor progression. However, the mechanisms that drive the anti-tumor functions of TAMs are not fully understood. The Src homology 2 domain-containing tyrosine phosphatase 2 (Shp2) has been reported to have tumor-suppressing roles in colorectal cancer (CRC). However, a role for Shp2 on TAMs in CRC has not been studied. Here we report that in CRC, Shp2 expression on TAMs is negatively associated with liver metastasis. TAMs require Shp2 for their anti-tumor functions in a cell-cell co-culture system and a mouse model of CRC. Mechanistically, absence of Shp2 on TAMs induces their polarization toward M2 phenotype through the activation of p-STAT3 and inhibition of p-NF-κB p65. The findings of our study imply that Shp2 is a key factor in the tumor microenvironment to facilitate the TAMs' tumor-suppressing functions in colorectal cancer. AJCR
Copyright © 2019.

Entities:  

Keywords:  Tumor-associated macrophages; colorectal cancer; liver metastasis; macrophage polarization; protein-tyrosine phosphatase Shp2

Year:  2019        PMID: 31598397      PMCID: PMC6780667     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  27 in total

Review 1.  Transcriptional regulation of macrophage polarization: enabling diversity with identity.

Authors:  Toby Lawrence; Gioacchino Natoli
Journal:  Nat Rev Immunol       Date:  2011-10-25       Impact factor: 53.106

2.  Regulation of macrophage arginase expression and tumor growth by the Ron receptor tyrosine kinase.

Authors:  Daniel R Sharda; Shan Yu; Manujendra Ray; Mario Leonardo Squadrito; Michele De Palma; Thomas A Wynn; Sidney M Morris; Pamela A Hankey
Journal:  J Immunol       Date:  2011-08-01       Impact factor: 5.422

Review 3.  Accessories to the crime: functions of cells recruited to the tumor microenvironment.

Authors:  Douglas Hanahan; Lisa M Coussens
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

4.  TGF-β secreted by tumor-associated macrophages promotes proliferation and invasion of colorectal cancer via miR-34a-VEGF axis.

Authors:  Danhua Zhang; Xinguang Qiu; Jianhua Li; Shouhua Zheng; Liwen Li; Hongchao Zhao
Journal:  Cell Cycle       Date:  2018-12-20       Impact factor: 4.534

5.  Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer.

Authors:  Marco Erreni; Alberto Mantovani; Paola Allavena
Journal:  Cancer Microenviron       Date:  2010-09-17

6.  High macrophage infiltration along the tumor front correlates with improved survival in colon cancer.

Authors:  Johan Forssell; Ake Oberg; Maria L Henriksson; Roger Stenling; Andreas Jung; Richard Palmqvist
Journal:  Clin Cancer Res       Date:  2007-03-01       Impact factor: 12.531

7.  Expression and clinical significance of tyrosine phosphatase SHP-2 in colon cancer.

Authors:  Peifen Cai; Wenjie Guo; Huaqin Yuan; Qian Li; Weicheng Wang; Yang Sun; Xiaomin Li; Yanhong Gu
Journal:  Biomed Pharmacother       Date:  2013-11-12       Impact factor: 6.529

Review 8.  American Cancer Society Colorectal Cancer Survivorship Care Guidelines.

Authors:  Khaled El-Shami; Kevin C Oeffinger; Nicole L Erb; Anne Willis; Jennifer K Bretsch; Mandi L Pratt-Chapman; Rachel S Cannady; Sandra L Wong; Johnie Rose; April L Barbour; Kevin D Stein; Katherine B Sharpe; Durado D Brooks; Rebecca L Cowens-Alvarado
Journal:  CA Cancer J Clin       Date:  2015-09-08       Impact factor: 508.702

Review 9.  Targeting macrophages: therapeutic approaches in cancer.

Authors:  Luca Cassetta; Jeffrey W Pollard
Journal:  Nat Rev Drug Discov       Date:  2018-10-26       Impact factor: 84.694

10.  SHP2 associates with nuclear localization of STAT3: significance in progression and prognosis of colorectal cancer.

Authors:  Yan Huang; Jie Wang; Fuao Cao; Hailong Jiang; An Li; Jianzhong Li; Lei Qiu; Hao Shen; Wenjun Chang; Chuanxiang Zhou; Yamin Pan; Yiming Lu
Journal:  Sci Rep       Date:  2017-12-14       Impact factor: 4.379

View more
  5 in total

1.  Knockdown of RNF183 suppressed proliferation of lung adenocarcinoma cells via inactivating the STAT3 signaling pathway.

Authors:  Guangbin Ye; Hongcheng Luo; Tingting Zhang; Tianshu Lan; Bo Ling; Zhongquan Qi
Journal:  Cell Cycle       Date:  2022-02-01       Impact factor: 5.173

2.  Allosteric inhibition reveals SHP2-mediated tumor immunosuppression in colon cancer by single-cell transcriptomics.

Authors:  Jian Gao; Zhigui Wu; Mingxia Zhao; Rui Zhang; Manru Li; Dongdong Sun; Haibo Cheng; Xianjia Qi; Yuxian Shen; Qiang Xu; Hongqi Chen; Dijun Chen; Yang Sun
Journal:  Acta Pharm Sin B       Date:  2021-08-11       Impact factor: 11.413

Review 3.  Functional and Therapeutic Significance of Tumor-Associated Macrophages in Colorectal Cancer.

Authors:  Yitong Li; Zhenmei Chen; Jiahao Han; Xiaochen Ma; Xin Zheng; Jinhong Chen
Journal:  Front Oncol       Date:  2022-02-02       Impact factor: 6.244

4.  A pan-cancer analysis confirms PTPN11's potential as a prognostic and immunological biomarker.

Authors:  Yapeng Cao; Haixia Duan; Ailing Su; Liran Xu; Baochang Lai
Journal:  Aging (Albany NY)       Date:  2022-07-08       Impact factor: 5.955

Review 5.  Clinical Application of Adaptive Immune Therapy in MSS Colorectal Cancer Patients.

Authors:  Danyang Wang; Hangyu Zhang; Tao Xiang; Gang Wang
Journal:  Front Immunol       Date:  2021-10-13       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.